| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |